Viral Inhibition of the Transporter Associated with Antigen Processing (TAP): A Striking Example of Functional Convergent Evolution

English version České info

Herpesviruses are large DNA viruses that are highly abundant within their host populations. Even in the presence of a healthy immune system, these viruses manage to cause lifelong infections. This persistence is partially mediated by the virus entering latency, a phase of infection characterized by limited viral protein expression. Moreover, herpesviruses have devoted a significant part of their coding capacity to immune evasion strategies. It is believed that the close coexistence of herpesviruses and their hosts has resulted in the evolution of viral proteins that specifically attack multiple arms of the host immune system. Cytotoxic T lymphocytes (CTLs) play an important role in antiviral immunity. CTLs recognize their target through viral peptides presented in the context of MHC molecules at the cell surface. Every herpesvirus studied to date encodes multiple immune evasion molecules that effectively interfere with specific steps of the MHC class I antigen presentation pathway. The transporter associated with antigen processing (TAP) plays a key role in the loading of viral peptides onto MHC class I molecules. This is reflected by the numerous ways herpesviruses have developed to block TAP function. In this review, we describe the characteristics and mechanisms of action of all known virus-encoded TAP inhibitors. Orthologs of these proteins encoded by related viruses are identified, and the conservation of TAP inhibition is discussed. A phylogenetic analysis of members of the family Herpesviridae is included to study the origin of these molecules. In addition, we discuss the characteristics of the first TAP inhibitor identified outside the herpesvirus family, namely, in cowpox virus. The strategies of TAP inhibition employed by viruses are very distinct and are likely to have been acquired independently during evolution. These findings and the recent discovery of a non-herpesvirus TAP inhibitor represent a striking example of functional convergent evolution.

Vyšlo v časopise: Viral Inhibition of the Transporter Associated with Antigen Processing (TAP): A Striking Example of Functional Convergent Evolution. PLoS Pathog 11(4): e32767. doi:10.1371/journal.ppat.1004743
Kategorie: Review
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1004743

Souhrn

Zdroje

1. McGeoch DJ, Gatherer D (2005) Integrating reptilian herpesviruses into the family herpesviridae. J Virol 79: 725–731. 15613300

2. Reits EA, Vos JC, Gromme M, Neefjes J (2000) The major substrates for TAP in vivo are derived from newly synthesized proteins. Nature 404: 774–778. 10783892

3. Princiotta MF, Finzi D, Qian SB, Gibbs J, Schuchmann S, et al. (2003) Quantitating protein synthesis, degradation, and endogenous antigen processing. Immunity 18: 343–354. 12648452

4. Lehner PJ, Surman MJ, Cresswell P (1998) Soluble tapasin restores MHC class I expression and function in the tapasin-negative cell line. 220. Immunity 8: 221–231. 9492003

5. Sadasivan B, Lehner PJ, Ortmann B, Spies T, Cresswell P (1996) Roles for calreticulin and a novel glycoprotein, tapasin, in the interaction of MHC class I molecules with TAP. Immunity 5: 103–114. 8769474

6. Wearsch PA, Cresswell P (2007) Selective loading of high-affinity peptides onto major histocompatibility complex class I molecules by the tapasin-ERp57 heterodimer. Nat Immunol 8: 873–881. 17603487

7. Kienast A, Preuss M, Winkler M, Dick TP (2007) Redox regulation of peptide receptivity of major histocompatibility complex class I molecules by ERp57 and tapasin. Nat Immunol 8: 864–872. 17603488

8. Koch J, Guntrum R, Tampe R (2006) The first N-terminal transmembrane helix of each subunit of the antigenic peptide transporter TAP is essential for independent tapasin binding. FEBS Lett 580: 4091–4096. 16828748

9. Leonhardt RM, Keusekotten K, Bekpen C, Knittler MR (2005) Critical role for the tapasin-docking site of TAP2 in the functional integrity of the MHC class I-peptide-loading complex. J Immunol 175: 5104–5114. 16210614

10. Peaper DR, Wearsch PA, Cresswell P (2005) Tapasin and ERp57 form a stable disulfide-linked dimer within the MHC class I peptide-loading complex. EMBO J 24: 3613–3623. 16193070

11. Raghavan M, Del Cid N, Rizvi SM, Peters LR (2008) MHC class I assembly: out and about. Trends Immunol 29: 436–443. doi: 10.1016/j.it.2008.06.004 18675588

12. Wearsch PA, Cresswell P (2008) The quality control of MHC class I peptide loading. Curr Opin Cell Biol 20: 624–631. doi: 10.1016/j.ceb.2008.09.005 18926908

13. Davison AJ, Eberle R, Ehlers B, Hayward GS, McGeoch DJ, et al. (2009) The order Herpesvirales. Arch Virol 154: 171–177. doi: 10.1007/s00705-008-0278-4 19066710

14. Staras SA, Dollard SC, Radford KW, Flanders WD, Pass RF, et al. (2006) Seroprevalence of cytomegalovirus infection in the United States, 1988–1994. Clin Infect Dis 43: 1143–1151. 17029132

15. Kilgore PE, Kruszon-Moran D, Seward JF, Jumaan A, Van Loon FP, et al. (2003) Varicella in Americans from NHANES III: implications for control through routine immunization. J Med Virol 70 Suppl 1: S111–118. 12627498

16. Epstein MA, Achong BG, Barr YM (1964) VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA. Lancet 1: 702–703. 14107961

17. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, et al. (1994) Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266: 1865–1869. 7997879

18. Kenneson A, Cannon MJ (2007) Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol 17: 253–276. 17579921

19. Ressing ME, Horst D, Griffin BD, Tellam J, Zuo J, et al. (2008) Epstein-Barr virus evasion of CD8(+) and CD4(+) T cell immunity via concerted actions of multiple gene products. Semin Cancer Biol 18: 397–408. doi: 10.1016/j.semcancer.2008.10.008 18977445

20. Liang C, Lee JS, Jung JU (2008) Immune evasion in Kaposi's sarcoma-associated herpes virus associated oncogenesis. Semin Cancer Biol 18: 423–436. doi: 10.1016/j.semcancer.2008.09.003 18948197

21. Middeldorp JM, Pegtel DM (2008) Multiple roles of LMP1 in Epstein-Barr virus induced immune escape. Semin Cancer Biol 18: 388–396. doi: 10.1016/j.semcancer.2008.10.004 19013244

22. Fenwick ML, Clark J (1982) Early and delayed shut-off of host protein synthesis in cells infected with herpes simplex virus. J Gen Virol 61 (Pt l): 121–125. 6288847

23. Kwong AD, Frenkel N (1987) Herpes simplex virus-infected cells contain a function(s) that destabilizes both host and viral mRNAs. Proc Natl Acad Sci U S A 84: 1926–1930. 3031658

24. Rowe M, Glaunsinger B, van Leeuwen D, Zuo J, Sweetman D, et al. (2007) Host shutoff during productive Epstein-Barr virus infection is mediated by BGLF5 and may contribute to immune evasion. Proc Natl Acad Sci U S A 104: 3366–3371. 17360652

25. Zuo J, Thomas W, van Leeuwen D, Middeldorp JM, Wiertz EJ, et al. (2008) The DNase of gammaherpesviruses impairs recognition by virus-specific CD8+ T cells through an additional host shutoff function. J Virol 82: 2385–2393. 18094150

26. Glaunsinger B, Chavez L, Ganem D (2005) The exonuclease and host shutoff functions of the SOX protein of Kaposi's sarcoma-associated herpesvirus are genetically separable. J Virol 79: 7396–7401. 15919895

27. Wiertz EJ, Jones TR, Sun L, Bogyo M, Geuze HJ, et al. (1996) The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. Cell 84: 769–779. 8625414

28. Park B, Spooner E, Houser BL, Strominger JL, Ploegh HL (2010) The HCMV membrane glycoprotein US10 selectively targets HLA-G for degradation. J Exp Med 207: 2033–2041. doi: 10.1084/jem.20091793 20713594

29. Wiertz EJ, Tortorella D, Bogyo M, Yu J, Mothes W, et al. (1996) Sec61-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction. Nature 384: 432–438. 8945469

30. Reusch U, Muranyi W, Lucin P, Burgert HG, Hengel H, et al. (1999) A cytomegalovirus glycoprotein re-routes MHC class I complexes to lysosomes for degradation. EMBO J 18: 1081–1091. 10022849

31. Lybarger L, Wang X, Harris MR, Virgin HWt, Hansen TH (2003) Virus subversion of the MHC class I peptide-loading complex. Immunity 18: 121–130. 12530981

32. Stevenson PG, May JS, Smith XG, Marques S, Adler H, et al. (2002) K3-mediated evasion of CD8(+) T cells aids amplification of a latent gamma-herpesvirus. Nat Immunol 3: 733–740. 12101398

33. Wang X, Herr RA, Chua WJ, Lybarger L, Wiertz EJ, et al. (2007) Ubiquitination of serine, threonine, or lysine residues on the cytoplasmic tail can induce ERAD of MHC-I by viral E3 ligase mK3. J Cell Biol 177: 613–624. 17502423

34. Jones TR, Wiertz EJ, Sun L, Fish KN, Nelson JA, et al. (1996) Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains. Proc Natl Acad Sci U S A 93: 11327–11333. 8876135

35. Ziegler H, Thale R, Lucin P, Muranyi W, Flohr T, et al. (1997) A mouse cytomegalovirus glycoprotein retains MHC class I complexes in the ERGIC/cis-Golgi compartments. Immunity 6: 57–66. 9052837

36. Zuo J, Currin A, Griffin BD, Shannon-Lowe C, Thomas WA, et al. (2009) The Epstein-Barr virus G-protein-coupled receptor contributes to immune evasion by targeting MHC class I molecules for degradation. PLoS Pathog 5: e1000255. doi: 10.1371/journal.ppat.1000255 19119421

37. Coscoy L, Ganem D (2000) Kaposi's sarcoma-associated herpesvirus encodes two proteins that block cell surface display of MHC class I chains by enhancing their endocytosis. Proc Natl Acad Sci U S A 97: 8051–8056. 10859362

38. Ishido S, Wang C, Lee BS, Cohen GB, Jung JU (2000) Downregulation of major histocompatibility complex class I molecules by Kaposi's sarcoma-associated herpesvirus K3 and K5 proteins. J Virol 74: 5300–5309. 10799607

39. Lehner PJ, Hoer S, Dodd R, Duncan LM (2005) Downregulation of cell surface receptors by the K3 family of viral and cellular ubiquitin E3 ligases. Immunol Rev 207: 112–125. 16181331

40. Hulpke S, Baldauf C, Tampe R (2012) Molecular architecture of the MHC I peptide-loading complex: one tapasin molecule is essential and sufficient for antigen processing. FASEB J 26: 5071–5080. doi: 10.1096/fj.12-217489 22923333

41. Koch J, Guntrum R, Heintke S, Kyritsis C, Tampe R (2004) Functional dissection of the transmembrane domains of the transporter associated with antigen processing (TAP). J Biol Chem 279: 10142–10147. 14679198

42. Androlewicz MJ, Cresswell P (1994) Human transporters associated with antigen processing possess a promiscuous peptide-binding site. Immunity 1: 7–14. 7889401

43. Koopmann JO, Post M, Neefjes JJ, Hammerling GJ, Momburg F (1996) Translocation of long peptides by transporters associated with antigen processing (TAP). Eur J Immunol 26: 1720–1728. 8765012

44. Momburg F, Roelse J, Hammerling GJ, Neefjes JJ (1994) Peptide size selection by the major histocompatibility complex-encoded peptide transporter. J Exp Med 179: 1613–1623. 8163941

45. Schumacher TN, Kantesaria DV, Heemels MT, Ashton-Rickardt PG, Shepherd JC, et al. (1994) Peptide length and sequence specificity of the mouse TAP1/TAP2 translocator. J Exp Med 179: 533–540. 8294864

46. van Endert PM, Tampe R, Meyer TH, Tisch R, Bach JF, et al. (1994) A sequential model for peptide binding and transport by the transporters associated with antigen processing. Immunity 1: 491–500. 7895159

47. Nijenhuis M, Hammerling GJ (1996) Multiple regions of the transporter associated with antigen processing (TAP) contribute to its peptide binding site. J Immunol 157: 5467–5477. 8955196

48. Armandola EA, Momburg F, Nijenhuis M, Bulbuc N, Fruh K, et al. (1996) A point mutation in the human transporter associated with antigen processing (TAP2) alters the peptide transport specificity. Eur J Immunol 26: 1748–1755. 8765016

49. Corradi V, Singh G, Tieleman DP (2012) The human transporter associated with antigen processing: molecular models to describe peptide binding competent states. J Biol Chem 287: 28099–28111. doi: 10.1074/jbc.M112.381251 22700967

50. Procko E, Ferrin-O'Connell I, Ng SL, Gaudet R (2006) Distinct structural and functional properties of the ATPase sites in an asymmetric ABC transporter. Mol Cell 24: 51–62. 17018292

51. Chen M, Abele R, Tampe R (2003) Peptides induce ATP hydrolysis at both subunits of the transporter associated with antigen processing. J Biol Chem 278: 29686–29692. 12777379

52. Lapinski PE, Raghuraman G, Raghavan M (2003) Nucleotide interactions with membrane-bound transporter associated with antigen processing proteins. J Biol Chem 278: 8229–8237. 12501238

53. Perria CL, Rajamanickam V, Lapinski PE, Raghavan M (2006) Catalytic site modifications of TAP1 and TAP2 and their functional consequences. J Biol Chem 281: 39839–39851. 17068338

54. Saveanu L, Daniel S, van Endert PM (2001) Distinct functions of the ATP binding cassettes of transporters associated with antigen processing: a mutational analysis of Walker A and B sequences. J Biol Chem 276: 22107–22113. 11290739

55. Dawson RJ, Locher KP (2006) Structure of a bacterial multidrug ABC transporter. Nature 443: 180–185. 16943773

56. Hohl M, Briand C, Grutter MG, Seeger MA (2012) Crystal structure of a heterodimeric ABC transporter in its inward-facing conformation. Nat Struct Mol Biol 19: 395–402. doi: 10.1038/nsmb.2267 22447242

57. Kim J, Wu S, Tomasiak TM, Mergel C, Winter MB, et al. (2015) Subnanometre-resolution electron cryomicroscopy structure of a heterodimeric ABC exporter. Nature 517: 396–400. doi: 10.1038/nature13872 25363761

58. Kodan A, Yamaguchi T, Nakatsu T, Sakiyama K, Hipolito CJ, et al. (2014) Structural basis for gating mechanisms of a eukaryotic P-glycoprotein homolog. Proc Natl Acad Sci U S A 111: 4049–4054. doi: 10.1073/pnas.1321562111 24591620

59. Srinivasan V, Pierik AJ, Lill R (2014) Crystal structures of nucleotide-free and glutathione-bound mitochondrial ABC transporter Atm1. Science 343: 1137–1140. doi: 10.1126/science.1246729 24604199

60. Geng J, Sivaramakrishnan S, Raghavan M (2013) Analyses of conformational states of the transporter associated with antigen processing (TAP) protein in a native cellular membrane environment. J Biol Chem 288: 37039–37047. doi: 10.1074/jbc.M113.504696 24196954

61. Grossmann N, Vakkasoglu AS, Hulpke S, Abele R, Gaudet R, et al. (2014) Mechanistic determinants of the directionality and energetics of active export by a heterodimeric ABC transporter. Nat Commun 5: 5419. doi: 10.1038/ncomms6419 25377891

62. Mayerhofer PU, Tampe R (2014) Antigen Translocation Machineries in Adaptive Immunity and Viral Immune Evasion. J Mol Biol. 427: 1102–1118 doi: 10.1016/j.jmb.2014.09.006 25224907

63. Spies T, DeMars R (1991) Restored expression of major histocompatibility class I molecules by gene transfer of a putative peptide transporter. Nature 351: 323–324. 2034277

64. Spies T, Cerundolo V, Colonna M, Cresswell P, Townsend A, et al. (1992) Presentation of viral antigen by MHC class I molecules is dependent on a putative peptide transporter heterodimer. Nature 355: 644–646. 1538752

65. de la Salle H, Hanau D, Fricker D, Urlacher A, Kelly A, et al. (1994) Homozygous human TAP peptide transporter mutation in HLA class I deficiency. Science 265: 237–241. 7517574

66. de la Salle H, Zimmer J, Fricker D, Angenieux C, Cazenave JP, et al. (1999) HLA class I deficiencies due to mutations in subunit 1 of the peptide transporter TAP1. J Clin Invest 103: R9–R13. 10074495

67. Moins-Teisserenc HT, Gadola SD, Cella M, Dunbar PR, Exley A, et al. (1999) Association of a syndrome resembling Wegener's granulomatosis with low surface expression of HLA class-I molecules. Lancet 354: 1598–1603. 10560675

68. de la Salle H, Saulquin X, Mansour I, Klayme S, Fricker D, et al. (2002) Asymptomatic deficiency in the peptide transporter associated to antigen processing (TAP). Clin Exp Immunol 128: 525–531. 12067308

69. Ahn K, Meyer TH, Uebel S, Sempe P, Djaballah H, et al. (1996) Molecular mechanism and species specificity of TAP inhibition by herpes simplex virus ICP47. EMBO J 15: 3247–3255. 8670825

70. Fruh K, Ahn K, Djaballah H, Sempe P, van Endert PM, et al. (1995) A viral inhibitor of peptide transporters for antigen presentation. Nature 375: 415–418. 7760936

71. Hill A, Jugovic P, York I, Russ G, Bennink J, et al. (1995) Herpes simplex virus turns off the TAP to evade host immunity. Nature 375: 411–415. 7760935

72. Tomazin R, Hill AB, Jugovic P, York I, van Endert P, et al. (1996) Stable binding of the herpes simplex virus ICP47 protein to the peptide binding site of TAP. EMBO J 15: 3256–3266. 8670826

73. Beinert D, Neumann L, Uebel S, Tampe R (1997) Structure of the viral TAP-inhibitor ICP47 induced by membrane association. Biochemistry 36: 4694–4700. 9109681

74. Galocha B, Hill A, Barnett BC, Dolan A, Raimondi A, et al. (1997) The active site of ICP47, a herpes simplex virus-encoded inhibitor of the major histocompatibility complex (MHC)-encoded peptide transporter associated with antigen processing (TAP), maps to the NH2-terminal 35 residues. J Exp Med 185: 1565–1572. 9151894

75. Neumann L, Kraas W, Uebel S, Jung G, Tampe R (1997) The active domain of the herpes simplex virus protein ICP47: a potent inhibitor of the transporter associated with antigen processing. J Mol Biol 272: 484–492. 9325106

76. Lacaille VG, Androlewicz MJ (1998) Herpes simplex virus inhibitor ICP47 destabilizes the transporter associated with antigen processing (TAP) heterodimer. J Biol Chem 273: 17386–17390. 9651323

77. Seyffer F, Tampe R (2015) ABC transporters in adaptive immunity. Biochim Biophys Acta 1850: 449–460. doi: 10.1016/j.bbagen.2014.05.022 24923865

78. Bigger JE, Martin DW (2004) Identification of an ICP47 homologue in simian agent 8 (SA8). Virus Genes 28: 223–225. 15077611

79. Tomazin R, van Schoot NE, Goldsmith K, Jugovic P, Sempe P, et al. (1998) Herpes simplex virus type 2 ICP47 inhibits human TAP but not mouse TAP. J Virol 72: 2560–2563. 9499125

80. Vasireddi M, Hilliard J (2012) Herpes B virus, macacine herpesvirus 1, breaks simplex virus tradition via major histocompatibility complex class I expression in cells from human and macaque hosts. J Virol 86: 12503–12511. doi: 10.1128/JVI.01350-12 22973043

81. McGeoch DJ, Davison AJ (1999) The molecular evolutionary history of the herpesviruses.; Domingo E, Webster R, Holland J, editors. London: Academic Press. 441–465 p.

82. Koppers-Lalic D, Reits EA, Ressing ME, Lipinska AD, Abele R, et al. (2005) Varicelloviruses avoid T cell recognition by UL49.5-mediated inactivation of the transporter associated with antigen processing. Proc Natl Acad Sci U S A 102: 5144–5149. 15793001

83. Verweij MC, Lipinska AD, Koppers-Lalic D, Quinten E, Funke J, et al. (2011) Structural and functional analysis of the TAP-inhibiting UL49.5 proteins of varicelloviruses. Mol Immunol 48: 2038–2051. doi: 10.1016/j.molimm.2011.06.438 21764135

84. Koppers-Lalic D, Verweij MC, Lipinska AD, Wang Y, Quinten E, et al. (2008) Varicellovirus UL 49.5 proteins differentially affect the function of the transporter associated with antigen processing, TAP. PLoS Pathog 4: e1000080. doi: 10.1371/journal.ppat.1000080 18516302

85. Verweij MC, Lipinska AD, Koppers-Lalic D, van Leeuwen WF, Cohen JI, et al. (2011) The capacity of UL49.5 proteins to inhibit TAP is widely distributed among members of the genus Varicellovirus. J Virol 85: 2351–2363. doi: 10.1128/JVI.01621-10 21159875

86. Jons A, Dijkstra JM, Mettenleiter TC (1998) Glycoproteins M and N of pseudorabies virus form a disulfide-linked complex. J Virol 72: 550–557. 9420258

87. Rudolph J, Seyboldt C, Granzow H, Osterrieder N (2002) The gene 10 (UL49.5) product of equine herpesvirus 1 is necessary and sufficient for functional processing of glycoprotein M. J Virol 76: 2952–2963. 11861861

88. Wu SX, Zhu XP, Letchworth GJ (1998) Bovine herpesvirus 1 glycoprotein M forms a disulfide-linked heterodimer with the U(L)49.5 protein. J Virol 72: 3029–3036. 9525625

89. Lipinska AD, Koppers-Lalic D, Rychlowski M, Admiraal P, Rijsewijk FA, et al. (2006) Bovine herpesvirus 1 UL49.5 protein inhibits the transporter associated with antigen processing despite complex formation with glycoprotein M. J Virol 80: 5822–5832. 16731921

90. Ahn K, Gruhler A, Galocha B, Jones TR, Wiertz EJ, et al. (1997) The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP. Immunity 6: 613–621. 9175839

91. Hengel H, Koopmann JO, Flohr T, Muranyi W, Goulmy E, et al. (1997) A viral ER-resident glycoprotein inactivates the MHC-encoded peptide transporter. Immunity 6: 623–632. 9175840

92. Lehner PJ, Karttunen JT, Wilkinson GW, Cresswell P (1997) The human cytomegalovirus US6 glycoprotein inhibits transporter associated with antigen processing-dependent peptide translocation. Proc Natl Acad Sci U S A 94: 6904–6909. 9192664

93. Hewitt EW, Gupta SS, Lehner PJ (2001) The human cytomegalovirus gene product US6 inhibits ATP binding by TAP. EMBO J 20: 387–396. 11157746

94. van Endert PM, Saveanu L, Hewitt EW, Lehner P (2002) Powering the peptide pump: TAP crosstalk with energetic nucleotides. Trends Biochem Sci 27: 454–461. 12217520

95. Halenius A, Momburg F, Reinhard H, Bauer D, Lobigs M, et al. (2006) Physical and functional interactions of the cytomegalovirus US6 glycoprotein with the transporter associated with antigen processing. J Biol Chem 281: 5383–5390. 16356928

96. Rawlinson WD, Farrell HE, Barrell BG (1996) Analysis of the complete DNA sequence of murine cytomegalovirus. J Virol 70: 8833–8849. 8971012

97. Davison AJ, Holton M, Dolan A, Dargan DJ, Gatherer D, et al. (2013) Comparative Genomics of Primate Cytomegaloviruses; Reddehase MJ, editor. Norwich, UK: Caister Academic Press.

98. Hislop AD, Ressing ME, van Leeuwen D, Pudney VA, Horst D, et al. (2007) A CD8+ T cell immune evasion protein specific to Epstein-Barr virus and its close relatives in Old World primates. J Exp Med 204: 1863–1873. 17620360

99. Horst D, van Leeuwen D, Croft NP, Garstka MA, Hislop AD, et al. (2009) Specific targeting of the EBV lytic phase protein BNLF2a to the transporter associated with antigen processing results in impairment of HLA class I-restricted antigen presentation. J Immunol 182: 2313–2324. doi: 10.4049/jimmunol.0803218 19201886

100. Horst D, Favaloro V, Vilardi F, van Leeuwen HC, Garstka MA, et al. (2011) EBV protein BNLF2a exploits host tail-anchored protein integration machinery to inhibit TAP. J Immunol 186: 3594–3605. doi: 10.4049/jimmunol.1002656 21296983

101. York IA, Roop C, Andrews DW, Riddell SR, Graham FL, et al. (1994) A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytes. Cell 77: 525–535. 8187174

102. Yuan J, Cahir-McFarland E, Zhao B, Kieff E (2006) Virus and cell RNAs expressed during Epstein-Barr virus replication. J Virol 80: 2548–2565. 16474161

103. Croft NP, Shannon-Lowe C, Bell AI, Horst D, Kremmer E, et al. (2009) Stage-specific inhibition of MHC class I presentation by the Epstein-Barr virus BNLF2a protein during virus lytic cycle. PLoS Pathog 5: e1000490. doi: 10.1371/journal.ppat.1000490 19557156

104. Quinn LL, Zuo J, Abbott RJ, Shannon-Lowe C, Tierney RJ, et al. (2014) Cooperation between Epstein-Barr virus immune evasion proteins spreads protection from CD8+ T cell recognition across all three phases of the lytic cycle. PLoS Pathog 10: e1004322. doi: 10.1371/journal.ppat.1004322 25144360

105. Goldsmith K, Chen W, Johnson DC, Hendricks RL (1998) Infected cell protein (ICP)47 enhances herpes simplex virus neurovirulence by blocking the CD8+ T cell response. J Exp Med 187: 341–348. 9449714

106. Burgos JS, Serrano-Saiz E, Sastre I, Valdivieso F (2006) ICP47 mediates viral neuroinvasiveness by induction of TAP protein following intravenous inoculation of herpes simplex virus type 1 in mice. J Neurovirol 12: 420–427. 17162658

107. Jugovic P, Hill AM, Tomazin R, Ploegh H, Johnson DC (1998) Inhibition of major histocompatibility complex class I antigen presentation in pig and primate cells by herpes simplex virus type 1 and 2 ICP47. J Virol 72: 5076–5084. 9573278

108. Verweij MC, Ressing ME, Knetsch W, Quinten E, Halenius A, et al. (2011) Inhibition of mouse TAP by immune evasion molecules encoded by non-murine herpesviruses. Mol Immunol 48: 835–845. doi: 10.1016/j.molimm.2010.12.008 21292324

109. Pande NT, Powers C, Ahn K, Fruh K (2005) Rhesus cytomegalovirus contains functional homologues of US2, US3, US6, and US11. J Virol 79: 5786–5798. 15827193

110. Hansen SG, Powers CJ, Richards R, Ventura AB, Ford JC, et al. (2010) Evasion of CD8+ T cells is critical for superinfection by cytomegalovirus. Science 328: 102–106. doi: 10.1126/science.1185350 20360110

111. Alzhanova D, Edwards DM, Hammarlund E, Scholz IG, Horst D, et al. (2009) Cowpox virus inhibits the transporter associated with antigen processing to evade T cell recognition. Cell Host Microbe 6: 433–445. doi: 10.1016/j.chom.2009.09.013 19917498

112. Byun M, Verweij MC, Pickup DJ, Wiertz EJ, Hansen TH, et al. (2009) Two mechanistically distinct immune evasion proteins of cowpox virus combine to avoid antiviral CD8 T cells. Cell Host Microbe 6: 422–432. doi: 10.1016/j.chom.2009.09.012 19917497

113. Luteijn RD, Hoelen H, Kruse E, van Leeuwen WF, Grootens J, et al. (2014) Cowpox Virus Protein CPXV012 Eludes CTLs by Blocking ATP Binding to TAP. J Immunol. 193: 1578–89. doi: 10.4049/jimmunol.1400964 25024387

114. Lin J, Eggensperger S, Hank S, Wycisk AI, Wieneke R, et al. (2014) A negative feedback modulator of antigen processing evolved from a frameshift in the cowpox virus genome. PLoS Pathog 10: e1004554. doi: 10.1371/journal.ppat.1004554 25503639

115. Elena SF, Sanjuan R (2005) Adaptive value of high mutation rates of RNA viruses: separating causes from consequences. J Virol 79: 11555–11558. 16140732

116. Finlay BB, McFadden G (2006) Anti-immunology: evasion of the host immune system by bacterial and viral pathogens. Cell 124: 767–782. 16497587

117. Abendroth A, Lin I, Slobedman B, Ploegh H, Arvin AM (2001) Varicella-zoster virus retains major histocompatibility complex class I proteins in the Golgi compartment of infected cells. J Virol 75: 4878–4888. 11312359

118. Eisfeld AJ, Yee MB, Erazo A, Abendroth A, Kinchington PR (2007) Downregulation of class I major histocompatibility complex surface expression by varicella-zoster virus involves open reading frame 66 protein kinase-dependent and-independent mechanisms. J Virol 81: 9034–9049. 17567702

119. Glosson NL, Gonyo P, May NA, Schneider CL, Ristow LC, et al. (2010) Insight into the mechanism of human herpesvirus 7 U21-mediated diversion of class I MHC molecules to lysosomes. J Biol Chem 285: 37016–37029. doi: 10.1074/jbc.M110.125849 20833720

120. Glosson NL, Hudson AW (2007) Human herpesvirus-6A and -6B encode viral immunoevasins that downregulate class I MHC molecules. Virology 365: 125–135. 17467766

121. Powers CJ, Fruh K (2008) Signal peptide-dependent inhibition of MHC class I heavy chain translation by rhesus cytomegalovirus. PLoS Pathog 4: e1000150. doi: 10.1371/journal.ppat.1000150 18833297

122. Zuo J, Quinn LL, Tamblyn J, Thomas WA, Feederle R, et al. (2011) The Epstein-Barr virus-encoded BILF1 protein modulates immune recognition of endogenously processed antigen by targeting major histocompatibility complex class I molecules trafficking on both the exocytic and endocytic pathways. J Virol 85: 1604–1614. doi: 10.1128/JVI.01608-10 21123379

123. Boname JM, Stevenson PG (2001) MHC class I ubiquitination by a viral PHD/LAP finger protein. Immunity 15: 627–636. 11672544

124. Byun M, Wang X, Pak M, Hansen TH, Yokoyama WM (2007) Cowpox virus exploits the endoplasmic reticulum retention pathway to inhibit MHC class I transport to the cell surface. Cell Host Microbe 2: 306–315. 18005752

125. Cox JH, Yewdell JW, Eisenlohr LC, Johnson PR, Bennink JR (1990) Antigen presentation requires transport of MHC class I molecules from the endoplasmic reticulum. Science 247: 715–718. 2137259

126. McCoy WHt, Wang X, Yokoyama WM, Hansen TH, Fremont DH (2012) Structural mechanism of ER retrieval of MHC class I by cowpox. PLoS Biol 10: e1001432. doi: 10.1371/journal.pbio.1001432 23209377

127. Long EO, Kim HS, Liu D, Peterson ME, Rajagopalan S (2013) Controlling natural killer cell responses: integration of signals for activation and inhibition. Annu Rev Immunol 31: 227–258. doi: 10.1146/annurev-immunol-020711-075005 23516982

128. Wilkinson GW, Tomasec P, Stanton RJ, Armstrong M, Prod'homme V, et al. (2008) Modulation of natural killer cells by human cytomegalovirus. J Clin Virol 41: 206–212. 18069056

129. Campbell JA, Trossman DS, Yokoyama WM, Carayannopoulos LN (2007) Zoonotic orthopoxviruses encode a high-affinity antagonist of NKG2D. J Exp Med 204: 1311–1317. 17548517

130. Grauwet K, Cantoni C, Parodi M, De Maria A, Devriendt B, et al. (2014) Modulation of CD112 by the alphaherpesvirus gD protein suppresses DNAM-1-dependent NK cell-mediated lysis of infected cells. Proc Natl Acad Sci U S A 111: 16118–16123. doi: 10.1073/pnas.1409485111 25352670

131. Nachmani D, Stern-Ginossar N, Sarid R, Mandelboim O (2009) Diverse herpesvirus microRNAs target the stress-induced immune ligand MICB to escape recognition by natural killer cells. Cell Host Microbe 5: 376–385. doi: 10.1016/j.chom.2009.03.003 19380116

132. Verweij MC, Koppers-Lalic D, Loch S, Klauschies F, de la Salle H, et al. (2008) The varicellovirus UL49.5 protein blocks the transporter associated with antigen processing (TAP) by inhibiting essential conformational transitions in the 6+6 transmembrane TAP core complex. J Immunol 181: 4894–4907. 18802093